How Do I Decide to Treat Patients with Geographic Atrophy?

Related

• 

  Histologic Correlates for OCT Signatures Occurring in AMD

  K. Bailey Freund, MD

  Updates from the Field

  2020

• 

  Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

  Peter A. Campochiaro, MD

  Updates from the Field

  2020

• 

  ARMD With Geographic Atrophy, Peripheral Degeneration

  James B. Soque, CRA, OCT-C, COA, FOPS

  Pamela Ann Weber, MD

  Retina Image Bank: Images of the Week

  2013